Internal Medicine, Cardiovascular Disease · Sugar Land, TX
NPI
1679721799
Since 2008
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
11555 University Blvd
Sugar Land, TX, 77478
Phone (713) 442-9100
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
596 services
Medicare patients, 2024
331
Average age 76
Drug cost, 2024
$1.1M
5,732 prescriptions
Company payments, 2025
$73.78
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Quocdai D Park was code 93010 (electrocardiogram), 252 times for 208 patients. In total Quocdai D Park billed 596 services in 28 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 252 | 208 | $6.09 | $1,536 |
| 99232 Hospital E&M - Subsequent | Facility | 124 | 56 | $59.47 | $7,374 |
| 99222 Hospital E&M - Initial | Facility | 50 | 48 | $96.69 | $4,834 |
| 99233 Hospital E&M - Subsequent | Facility | 49 | 30 | $89.64 | $4,392 |
| 93306 Echocardiography (TTE/TEE) | Facility | 40 | 39 | $51.46 | $2,058 |
| 99223 Hospital E&M - Initial | Facility | 18 | 18 | $128.66 | $2,316 |
| 99214 Office E&M - Established | Office | 16 | 12 | $75.84 | $1,214 |
By year: 2022 $76K for 1,045 services; 2023 $59K for 751 services; 2024 $26K for 596 services.
Medicare prescription drug claims, 2024
In 2024, the drug Quocdai D Park prescribed most often to Medicare patients was Furosemide, with 513 prescriptions and refills. In total Quocdai D Park wrote 5,732 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Furosemide Generic | 513 | 1,384 | 201 | $3,521 |
| Metoprolol Succinate Generic | 446 | 1,251 | 196 | $10K |
| Carvedilol Generic | 397 | 1,099 | 155 | $6,918 |
| Atorvastatin Calcium Generic | 385 | 1,093 | 167 | $11K |
| Eliquis Apixaban | 346 | 740 | 114 | $413K |
| Valsartan-Hydrochlorothiazide Valsartan/Hydrochlorothiazide | 302 | 819 | 121 | $20K |
| Amlodipine Besylate Generic | 272 | 702 | 115 | $2,277 |
| Rosuvastatin Calcium Generic | 248 | 717 | 113 | $11K |
| Valsartan Generic | 247 | 692 | 97 | $17K |
| Clopidogrel Clopidogrel Bisulfate | 139 | 403 | 63 | $3,835 |
| Diltiazem 24hr Er Diltiazem Hcl | 134 | 366 | 59 | $4,034 |
| Potassium Chloride Generic | 127 | 234 | 45 | $1,992 |
| Amiodarone Hcl Generic | 116 | 304 | 53 | $8,020 |
| Olmesartan Medoxomil Generic | 116 | 320 | 52 | $12K |
| Hydralazine Hcl Generic | 114 | 316 | 47 | $4,833 |
Brand drugs: 823 claims; generic drugs: 4,909 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Quocdai D Park $73.78 ($73.78 in general payments such as food, travel and fees) from 1 company. The largest payer was Shockwave Medical, Inc with $73.78.
| Company | Payments | Amount |
|---|---|---|
| Shockwave Medical, Inc JNJ | 4 | $73.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.